Endocrine Reviews
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

14.661

-3.3 %

Journal Impact IF Trend

Related Journals

Popular Journals

Endocrine Reviews

The 2019-2020 Journal Impact IF of Endocrine Reviews is 14.661, which is just updated in 2020.

Endocrine Reviews Impact Factor
Highest IF
21.059
Highest Journal Impact IF

The highest Journal Impact IF of Endocrine Reviews is 21.059.

Lowest IF
14.661
Lowest Journal Impact IF

The lowest Journal Impact IF of Endocrine Reviews is 14.661.

Total Growth Rate
-26.4%
IF Total Growth Rate

The total growth rate of Endocrine Reviews IF is -26.4%.

Annual Growth Rate
-2.9%
IF Annual Growth Rate

The annual growth rate of Endocrine Reviews IF is -2.9%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Endocrinology, Diabetes and Metabolism Q1 5/217

Endocrinology, Diabetes and Metabolism 97%

Endocrinology Q1 4/118

Endocrinology 97%

Journal Impact IF Ranking

· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Endocrine Reviews is Q1. Endocrine Reviews has been ranked #5 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Endocrine Reviews is around 97% in the field of Endocrinology, Diabetes and Metabolism.
· In the Endocrinology research field, the Quartile of Endocrine Reviews is Q1. Endocrine Reviews has been ranked #4 over 118 related journals in the Endocrinology research category. The ranking percentile of Endocrine Reviews is around 97% in the field of Endocrinology.

Endocrine Reviews Impact Factor 2020-2021 Prediction

Endocrine Reviews Impact Factor Predition System

Endocrine Reviews Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
1488
Total Citations
546412

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 14.661
2018-2019 15.167
2017-2018 15.545
2016-2017 15.745
2015-2016 14.898
2014-2015 21.059
2013-2014 19.358
2012-2013 14.873
2011-2012 19.929
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Endocrine Reviews is 14.661
· The 2018-2019 Journal Impact IF of Endocrine Reviews is 15.167
· The 2017-2018 Journal Impact IF of Endocrine Reviews is 15.545
· The 2016-2017 Journal Impact IF of Endocrine Reviews is 15.745
· The 2015-2016 Journal Impact IF of Endocrine Reviews is 14.898
· The 2014-2015 Journal Impact IF of Endocrine Reviews is 21.059
· The 2013-2014 Journal Impact IF of Endocrine Reviews is 19.358
· The 2012-2013 Journal Impact IF of Endocrine Reviews is 14.873
· The 2011-2012 Journal Impact IF of Endocrine Reviews is 19.929

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1979 0 6
1980 22 13
1981 23 212
1982 17 488
1983 21 903
1984 22 1274
1985 19 1639
1986 30 2048
1987 24 2689
1988 25 2962
1989 29 3454
1990 26 4038
1991 25 4372
1992 38 4753
1993 46 5052
1994 41 5531
1995 32 6757
1996 35 7602
1997 42 9718
1998 41 11511
1999 43 12221
2000 34 12660
2001 33 14647
2002 41 15466
2003 36 16238
2004 32 17427
2005 40 19808
2006 35 21921
2007 30 22800
2008 38 24108
2009 43 25521
2010 128 25920
2011 40 26987
2012 37 27699
2013 32 28494
2014 67 27630
2015 26 24894
2016 29 22447
2017 29 21399
2018 41 18050
2019 53 19546
2020 42 23562
2021 1 1945
Publications Cites Dataset

· The Endocrine Reviews has published 0 reports and received 6 citations in 1979.
· The Endocrine Reviews has published 22 reports and received 13 citations in 1980.
· The Endocrine Reviews has published 23 reports and received 212 citations in 1981.
· The Endocrine Reviews has published 17 reports and received 488 citations in 1982.
· The Endocrine Reviews has published 21 reports and received 903 citations in 1983.
· The Endocrine Reviews has published 22 reports and received 1274 citations in 1984.
· The Endocrine Reviews has published 19 reports and received 1639 citations in 1985.
· The Endocrine Reviews has published 30 reports and received 2048 citations in 1986.
· The Endocrine Reviews has published 24 reports and received 2689 citations in 1987.
· The Endocrine Reviews has published 25 reports and received 2962 citations in 1988.
· The Endocrine Reviews has published 29 reports and received 3454 citations in 1989.
· The Endocrine Reviews has published 26 reports and received 4038 citations in 1990.
· The Endocrine Reviews has published 25 reports and received 4372 citations in 1991.
· The Endocrine Reviews has published 38 reports and received 4753 citations in 1992.
· The Endocrine Reviews has published 46 reports and received 5052 citations in 1993.
· The Endocrine Reviews has published 41 reports and received 5531 citations in 1994.
· The Endocrine Reviews has published 32 reports and received 6757 citations in 1995.
· The Endocrine Reviews has published 35 reports and received 7602 citations in 1996.
· The Endocrine Reviews has published 42 reports and received 9718 citations in 1997.
· The Endocrine Reviews has published 41 reports and received 11511 citations in 1998.
· The Endocrine Reviews has published 43 reports and received 12221 citations in 1999.
· The Endocrine Reviews has published 34 reports and received 12660 citations in 2000.
· The Endocrine Reviews has published 33 reports and received 14647 citations in 2001.
· The Endocrine Reviews has published 41 reports and received 15466 citations in 2002.
· The Endocrine Reviews has published 36 reports and received 16238 citations in 2003.
· The Endocrine Reviews has published 32 reports and received 17427 citations in 2004.
· The Endocrine Reviews has published 40 reports and received 19808 citations in 2005.
· The Endocrine Reviews has published 35 reports and received 21921 citations in 2006.
· The Endocrine Reviews has published 30 reports and received 22800 citations in 2007.
· The Endocrine Reviews has published 38 reports and received 24108 citations in 2008.
· The Endocrine Reviews has published 43 reports and received 25521 citations in 2009.
· The Endocrine Reviews has published 128 reports and received 25920 citations in 2010.
· The Endocrine Reviews has published 40 reports and received 26987 citations in 2011.
· The Endocrine Reviews has published 37 reports and received 27699 citations in 2012.
· The Endocrine Reviews has published 32 reports and received 28494 citations in 2013.
· The Endocrine Reviews has published 67 reports and received 27630 citations in 2014.
· The Endocrine Reviews has published 26 reports and received 24894 citations in 2015.
· The Endocrine Reviews has published 29 reports and received 22447 citations in 2016.
· The Endocrine Reviews has published 29 reports and received 21399 citations in 2017.
· The Endocrine Reviews has published 41 reports and received 18050 citations in 2018.
· The Endocrine Reviews has published 53 reports and received 19546 citations in 2019.
· The Endocrine Reviews has published 42 reports and received 23562 citations in 2020.
· The Endocrine Reviews has published 1 reports and received 1945 citations in 2021.
· The total publications of Endocrine Reviews is 1488.
· The total citations of Endocrine Reviews is 546412.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Endocrine Reviews | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Endocrine Reviews Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Endocrine Reviews during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Endocrine Reviews.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Endocrine Reviews
Journal Profile

About

Endocrine Reviews publishes bimonthly, including concise timely reviews updating key mechanistic and clinical concepts, as well as more comprehensive, authoritative review articles spanning both experimental and clinical endocrinology themes. Endocrine Reviews will consider topics that inform clinical practice based on emerging and established evidence from clinical research as well as reviews of advances in endocrine science emanating from studies of cell biology, immunology, pharmacology, genetics, molecular biology, neuroscience, reproductive medicine, and pediatric endocrinology. Endocrine Reviews is a bimonthly peer-reviewed academic journal for review articles in endocrinology published by the Endocrine Society. Its 2016 impact factor is 15.745.According to the Journal Citation Reports, the journal has a 2016 impact factor of 0.506.

Highly Cited Keywords

ISSN
0163-769X
ISSN

The ISSN of Endocrine Reviews is 0163-769X . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1945-7189
ISSN (Online)

The ISSN (Online) of Endocrine Reviews is 1945-7189 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
The Endocrine Society
Publisher

Endocrine Reviews is published by The Endocrine Society .

Publication Frequency
Bimonthly
Publication Frequency

Endocrine Reviews publishes reports Bimonthly .

Coverage
1980 - Present
Coverage

The Publication History of Endocrine Reviews covers 1980 - Present .

Open Access
NO
Open Access

Endocrine Reviews is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Endocrine Reviews. Endocrine Reviews is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
English
Language

The language of Endocrine Reviews is English .

Country/Region
United States
Country/Region

The publisher of Endocrine Reviews is The Endocrine Society , which locates in United States .

Selected Articles

Full Title Authors
Full Title Authors
Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease M Van Den Berg Susan · D Van Dam Andrea · C N Rensen Patrick · P J De Winther Menno · Lutgens Esther · Lutgens Esther
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment Teresa Maria Seccia · Brasilina Caroccia · Elise P. Gomez-Sanchez · Celso E. Gomez-Sanchez · Gian Paolo Rossi · Gian Paolo Rossi
The science of obesity management: An endocrine society scientific statement Claus Højbjerg Gravholt · Simon Chang · Mikkel Wallentin · Jens Fedder · Philip J. Moore · Anne Skakkebæk · Anne Skakkebæk
The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism George A. Bray · William E. Heisel · Ashkan Afshin · Michael D. Jensen · William H. Dietz · Michael W. Long · Robert F. Kushner · Stephen R. Daniels · Thomas A. Wadden · Adam Gilden Tsai · Frank B. Hu · John M. Jakicic · Donna H. Ryan · Bruce M. Wolfe · Thomas H. Inge · Thomas H. Inge · Thomas H. Inge
The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations Vincent Prevot · Vincent Prevot · Bénédicte Dehouck · Bénédicte Dehouck · Ariane Sharif · Ariane Sharif · Philippe Ciofi · Philippe Ciofi · Paolo Giacobini · Paolo Giacobini · Jerome Clasadonte · Jerome Clasadonte · Jerome Clasadonte
11β-HSD1 in Human Fetal Membranes as a Potential Therapeutic Target for Preterm Birth Amin Ardestani · Kathrin Maedler · Kathrin Maedler
The Extending Spectrum of NPC1-Related Human Disorders: From Niemann–Pick C1 Disease to Obesity Wangsheng Wang · Zi Jiang Chen · Leslie Myatt · Kang Sun · Kang Sun
Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms Abdikarim Abdullahi · Abdikarim Abdullahi · Abdikarim Abdullahi · Marc G. Jeschke · Marc G. Jeschke
Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules Janet P. Hapgood · Charu Kaushic · Zdenek Hel · Zdenek Hel
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans E.J. de Koster · L.F. de Geus-Oei · Olaf M. Dekkers · I.A. van Engen-van Grunsven · J. Hamming · Eleonora P. M. Corssmit · Hans Morreau · Abbey Schepers · Johannes W. A. Smit · Wim J.G. Oyen · Wim J.G. Oyen · D. Vriens · D. Vriens
The Biology of Normal Zona Glomerulosa And Aldosterone-Producing Adenoma: Pathological Implications Pujadas Gemma · J Drucker Daniel · J Drucker Daniel
Gonadotropins and their analogues: current and potential clinical applications Ali Abbara · Sophie Clarke · Waljit S. Dhillo · Waljit S. Dhillo
Extracellular vesicles in human reproduction in health and disease Peter J. Snyder · Shalender Bhasin · Glenn R. Cunningham · Alvin M. Matsumoto · Alisa J. Stephens-Shields · Jane A. Cauley · Thomas M. Gill · Elizabeth Barrett-Connor · Ronald S. Swerdloff · Christina Wang · Kristine E. Ensrud · Cora E. Lewis · John T. Farrar · David Cella · Raymond C. Rosen · Marco Pahor · Jill P. Crandall · Mark E. Molitch · Susan M. Resnick · Matthew J. Budoff · Emile R. Mohler · Nanette K. Wenger · Harvey J. Cohen · Stanley L. Schrier · Tony M. Keaveny · David L. Kopperdahl · David S. Lee · Denise Cifelli · Susan S. Ellenberg · Susan S. Ellenberg
The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway Ross Calley Anderson · Claire L. Newton · Richard A. Anderson · Robert P. Millar · Robert P. Millar · Robert P. Millar
Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy Mylène Tajan · Romain Paccoud · Sophie Branka · Thomas Edouard · Armelle Yart · Armelle Yart
Regulation of Skeletal Homeostasis Rowan Hardy · Hong Zhou · Markus J. Seibel · Markus J. Seibel · Mark S. Cooper · Mark S. Cooper · Mark S. Cooper
Estrogen Receptors: New Directions in the New Millennium Mone Zaidi · Tony Yuen · Li Sun · Clifford J. Rosen · Clifford J. Rosen
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes Sylvia C. Hewitt · Kenneth S. Korach · Kenneth S. Korach
Two Hormones for One Receptor: Evolution, Biochemistry, Actions, and Pathophysiology of LH and hCG Megan Capozzi · Richard D. Dimarchi · Richard D. Dimarchi · Matthias H. Tschöp · Brian Finan · Jonathan E. Campbell · Jonathan E. Campbell
At the Crossroads of Fate—Somatic Cell Lineage Specification in the Fetal Gonad Livio Casarini · Daniele Santi · Giulia Brigante · Manuela Simoni · Manuela Simoni
Pituitary Diseases and Bone Emmi Rotgers · Anne Jørgensen · Humphrey Hung-Chang Yao · Humphrey Hung-Chang Yao
Sex and Gender Differences Research Design for Basic, Clinical, and Population Studies: Essentials for Investigators Reuben L. Smith · Maarten R. Soeters · Rob C. I. Wüst · Riekelt H. Houtkooper · Riekelt H. Houtkooper
Klinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology Carlos Simón · David W. Greening · David Bolumar · Nuria Balaguer · Lois A. Salamonsen · Lois A. Salamonsen · Felipe Vilella · Felipe Vilella
Lessons From the Testosterone Trials David J. Handelsman · David J. Handelsman · Angelica Lindén Hirschberg · Angelica Lindén Hirschberg · Stéphane Bermon · Stéphane Bermon
The Circadian Clock in White and Brown Adipose Tissue: Mechanistic, Endocrine, and Clinical Aspects Vicente Gilsanz · Tishya A. L. Wren · Skorn Ponrartana · Stefano Mora · Clifford J. Rosen · Clifford J. Rosen
Coupling the circadian clock to homeostasis: the role of Period in timing physiology Laura van Iersel · Karen E Brokke · Roger A.H. Adan · Roger A.H. Adan · Lauren C M Bulthuis · Erica L.T. van den Akker · Hanneke M. van Santen · Hanneke M. van Santen
Skeletal and extra-skeletal actions of vitamin D: Current evidence and outstanding questions Paishiun N. Hsieh · Liyan Fan · David R. Sweet · Mukesh K. Jain · Mukesh K. Jain
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk Roger Bouillon · Claudio Marcocci · Geert Carmeliet · Daniel D. Bikle · John H. White · Bess Dawson-Hughes · Paul Lips · Craig Munns · Marise Lazaretti-Castro · Andrea Giustina · John P. Bilezikian · John P. Bilezikian
Endocrinology of transgender medicine Pratik Sandesara · Salim S. Virani · Sergio Fazio · Michael D. Shapiro · Michael D. Shapiro
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm Guy T’Sjoen · Jon Arcelus · Louis Gooren · Daniel T. Klink · Vin Tangpricha · Vin Tangpricha
Emerging biomarkers, tools, and treatments for diabetic polyneuropathy Julien Favresse · M. C. Burlacu · Dominique Maiter · Dominique Maiter · Damien Gruson · Damien Gruson · Damien Gruson
MELATONIN AS A HORMONE: NEW PHYSIOLOGICAL AND CLINICAL INSIGHTS Gidon J. Bönhof · Christian Herder · Alexander Strom · Nikolaos Papanas · Michael Roden · Dan Ziegler · Dan Ziegler
Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy José Cipolla-Neto · Fernanda Gaspar do Amaral · Fernanda Gaspar do Amaral
Endocrine toxicity of cancer immunotherapy targeting immune checkpoints Terry J. Smith · Terry J. Smith · Joseph A M J L Janssen · Joseph A M J L Janssen · Joseph A M J L Janssen
Pathophysiology and Individualized Treatment for Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review Lee-Shing Chang · Romualdo Barroso-Sousa · Sara M. Tolaney · F. Stephen Hodi · Ursula B. Kaiser · Le Min · Le Min
Atypical Femur Fractures – Review of epidemiology, relationship to bisphosphonates, prevention and clinical management Pureum Kim · Henrik Oster · Hendrik Lehnert · Sebastian M. Schmid · Nicole Salamat · Johanna L. Barclay · Erik Maronde · Warrick J. Inder · Warrick J. Inder · Oliver Rawashdeh · Oliver Rawashdeh
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance Nadia Bougarne · Basiel Weyers · Sofie Desmet · Julie Deckers · David Ray · Bart Staels · Karolien De Bosscher · Karolien De Bosscher
Systemic complications of acromegaly and the impact of the current treatment landscape: an update Dennis M. Black · Bo Abrahamsen · Mary L. Bouxsein · Thomas A. Einhorn · Nicola Napoli · Nicola Napoli
Effects of anorexia nervosa on bone metabolism Mônica R. Gadelha · Leandro Kasuki · Dawn St Lim · Maria Fleseriu · Maria Fleseriu
Effects of Leptin on the Skeleton Pouneh K. Fazeli · Anne Klibanski · Anne Klibanski
Structural and Functional Biology of Aldo-Keto Reductase Steroid Transforming Enzymes Ian R. Reid · Paul A. Baldock · Jillian Cornish · Jillian Cornish
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment Trevor M. Penning · Phumvadee Wangtrakuldee · Richard J. Auchus · Richard J. Auchus
Fibroblast Growth Factor 15/19 - From Basic Functions to Therapeutic Perspectives Anand Vaidya · Paolo Mulatero · Rene Baudrand · Gail K. Adler · Gail K. Adler
Children born small for gestational age: differential diagnosis, molecular-genetic evaluation and implications Emmanuel Somm · François R. Jornayvaz · François R. Jornayvaz
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms Finken Mjj · van der Steen M · Smeets Ccj · Walenkamp Mje · de Bruin C · Hokken-Koelega Acs · Wit Jm · Wit Jm
Molecular Actions of PPARα in Lipid Metabolism and Inflammation Karen D. Corbin · Kimberly A. Driscoll · Richard E. Pratley · Steven R. Smith · David M. Maahs · Elizabeth J. Mayer-Davis · Elizabeth J. Mayer-Davis
Sexual Dimorphism and the Origins of Human Spinal Health Bruno Madeo · Elda Kara · K. Cion · Silvia Vezzani · Manuela Simoni · Vincenzo Rochira · Vincenzo Rochira
The Krüppel-Like Factors and Control of Energy Homeostasis Jeffrey S. Flier · Jeffrey S. Flier
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment Oren Froy · Marta Garaulet · Marta Garaulet
Ovarian Follicular Theca Cell Recruitment, Differentiation, and Impact on Fertility: 2017 Update Ana Claudia Latronico · Michael R. Rickels · David J. Handelsman · Roberto Salvatori · Roberto Salvatori
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy Franck Mauvais-Jarvis · JoAnn E. Manson · JoAnn E. Manson · John C. Stevenson · Vivian Fonseca · Vivian Fonseca
Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications Wen-Chih Lee · Anyonya R. Guntur · Fanxin Long · Clifford J. Rosen · Clifford J. Rosen
Energy Metabolism of the Osteoblast: Implications for Osteoporosis Ronald S. Swerdloff · Robert E. Dudley · Stephanie T. Page · Christina Wang · Wael A. Salameh · Wael A. Salameh
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels Carla Scaroni · Marialuisa Zilio · Michelangelo Foti · Marco Boscaro · Marco Boscaro
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management Bradley D. Anawalt · Bradley D. Anawalt
Is Dihydrotestosterone a Classic Hormone Simon Chang · Ole Halfdan Larsen · Anne Skakkebæk · Anders Bojesen · Claus Højbjerg Gravholt · Vakur Bor · Anna-Marie Bloch Münster · Anna-Marie Bloch Münster
Obesity Pathogenesis: An Endocrine Society Scientific Statement Matthew T. Drake · Bart L. Clarke · Merry Jo Oursler · Sundeep Khosla · Sundeep Khosla
Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned Megan R. Haymart · Nazanene H. Esfandiari · Michael T. Stang · Julia Ann Sosa · Julia Ann Sosa
Controversies in the Management of Low-Risk Differentiated Thyroid Cancer Antonino Belfiore · Roberta Malaguarnera · Veronica Vella · Michael C. Lawrence · Michael C. Lawrence · Laura Sciacca · Francesco Frasca · Andrea Morrione · Riccardo Vigneri · Riccardo Vigneri
Taming the Flames: Targeting White Adipose Tissue Browning in Hypermetabolic Conditions Amel Lamri · Marie Pigeyre · Marie Pigeyre · William S. Garver · David Meyre · David Meyre
Insulin Receptor Isoforms in Physiology and Disease: An Updated View Anna L Goldman · Shalender Bhasin · Frederick C. W. Wu · Meenakshi Krishna · Alvin M. Matsumoto · Ravi Jasuja · Ravi Jasuja
A Reappraisal of Testosterones Binding in Circulation: Physiological and Clinical Implications Luba Sominsky · Deborah M. Hodgson · Eileen A. McLaughlin · Eileen A. McLaughlin · Roger Smith · Hannah M Wall · Sarah J. Spencer · Sarah J. Spencer
Linking Stress and Infertility: A Novel Role for Ghrelin Maria-Christina Zennaro · Maria-Christina Zennaro · Sheerazed Boulkroun · Sheerazed Boulkroun · Fabio Luiz Fernandes-Rosa · Fabio Luiz Fernandes-Rosa · Fabio Luiz Fernandes-Rosa
Pulmonary Function and Sleep Breathing: Two New Targets for Type 2 Diabetes Care Abraham S Meijnikman · Victor Gerdes · Max Nieuwdorp · Hilde Herrema · Hilde Herrema
Platelet Aggregation Is Not Increased in Testosterone Treatment Naive Klinefelter Syndrome Michael W. Schwartz · Randy J. Seeley · Lori M. Zeltser · Adam Drewnowski · Eric Ravussin · Leanne M. Redman · Rudolph L. Leibel · Rudolph L. Leibel
Genetic Causes of Functional Adrenocortical Adenomas Harald Staiger · Michaela Keuper · Lucia Berti · Martin Hrabě de Angelis · Hans-Ulrich Häring · Hans-Ulrich Häring
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men David J. Handelsman · David J. Handelsman
Free Testosterone: Pumping up the Tires or Ending the Free Ride? Joakim Crona · Joakim Crona · David Taïeb · Karel Pacak · Karel Pacak
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification D M Potter Gregory · J Skene Debra · Arendt Josephine · E Cade Janet · J Grant Peter · J Hardie Laura · J Hardie Laura
肥満における褐色(褐色化)脂肪組織の免疫調節 Gherardo Mazziotti · Stefano Frara · Andrea Giustina · Andrea Giustina
グルカゴン受容体スーパーファミリーペプチドの血管生物学:作用機構的,臨床的関連性 JoAnne S. Richards · Yi A. Ren · Nicholes Candelaria · Jaye E Adams · Aleksandar Rajkovic · Aleksandar Rajkovic
From the Editor-in-Chief of Endocrine Reviews on the Occasion of the 2016 Centennial of the Endocrine Society Basil Rapoport · Sandra M. McLachlan · Sandra M. McLachlan
The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis Peter J. Tebben · Ravinder J. Singh · Rajiv Kumar · Rajiv Kumar
The Multifaceted Haptoglobin in the Context of Adipose Tissue and Metabolism Lonnele J. Ball · Oxana Palesh · Lance J. Kriegsfeld · Lance J. Kriegsfeld · Lance J. Kriegsfeld
A Track Record on SHOX: From Basic Research to Complex Models and Therapy Margherita Maffei · Ilaria Barone · Gaia Scabia · Ferruccio Santini · Ferruccio Santini
Bone Disease in Thalassemia: A Molecular and Clinical Overview Antonio Marchini · Tsutomu Ogata · Gudrun Rappold · Gudrun Rappold
TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective Phillip Wong · Phillip Wong · Peter J. Fuller · Peter J. Fuller · Matthew T. Gillespie · Frances Milat · Frances Milat · Frances Milat
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus Alexandra Kautzky-Willer · Jürgen Harreiter · Giovanni Pacini · Giovanni Pacini
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance J.H.D. Bassett · Graham R. Williams · Graham R. Williams
Current Understanding on Role of the Wnt Signaling Pathway Effector TCF7L2 in Glucose Homeostasis Tianru Jin · Tianru Jin
Estrogens, Neuroinflammation, and Neurodegeneration Robert L. Rosenfield · David A. Ehrmann · David A. Ehrmann
Notch Signaling and the Skeleton Stefano Zanotti · Ernesto Canalis · Ernesto Canalis
Letter to the Editor: Response toSecond Scientific Statement on Endocrine-Disrupting Chemicalsby Gore et al David Dix · Whitney Weber · Whitney Weber
Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes Yisheng Yang · Lawrence Chan · Lawrence Chan
Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions Sze Choong Wong · Ross Dobie · M A Altowati · George A. Werther · Colin Farquharson · S.F. Ahmed · S.F. Ahmed
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment Alessandro Villa · Elisabetta Vegeto · Angelo Poletti · Adriana Maggi · Adriana Maggi
The functional and clinical significance of the 24-h rhythm of circulating glucocorticoids Gregory D. M. Potter · Debra J. Skene · Josephine Arendt · Janet E Cade · Peter J. Grant · Laura J. Hardie · Laura J. Hardie
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited Elena J. Tucker · Elena J. Tucker · Sonia Grover · Sonia Grover · Anne Bachelot · Anne Bachelot · Philippe Touraine · Philippe Touraine · Andrew H. Sinclair · Andrew H. Sinclair · Andrew H. Sinclair
Premature Ovarian Insufficiency: New Perspectives on Genetic Cause and Phenotypic Spectrum Henrik Oster · Etienne Challet · Volker Ott · Emanuela Arvat · E. Ronald de Kloet · Derk-Jan Dijk · Stafford L. Lightman · Eve Van Cauter · Eve Van Cauter
Centennial Celebration: Endocrine Reviews Past Highlights for November and December Albert Lecube · Albert Lecube · Rafael Simó · Rafael Simó · Maria Pallayova · Maria Pallayova · Naresh M. Punjabi · Carolina López-Cano · Cecilia Turino · Cristina Hernández · Cristina Hernández · Ferran Barbé · Ferran Barbé · Ferran Barbé
Circadian Rhythm and Sleep Disruption: Causes Metabolic Consequences and Countermeasures Yu Zhang · Yu Zhang · Xinghui Sun · Xinghui Sun · Basak Icli · Mark W. Feinberg · Mark W. Feinberg
Premorbid obesity protects against critical illness-induced muscle wasting and weakness Yuka Kinoshita · Seiji Fukumoto · Seiji Fukumoto
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes Vijay Shivaswamy · Brian P. Boerner · Jennifer L. Larsen · Jennifer L. Larsen
Drug-induced HPA axis alterations during acute critical illness: a multivariable association study Chloë Goossens · Mirna Bastos Marques · Sarah Derde · Sarah Vander Perre · Thomas Dufour · Steven Thiessen · Fabian Güiza · Thomas Janssens · Greet Hermans · Ilse Vanhorebeek · Katrien De Bock · Greet Van den Berghe · Lies Langouche · Lies Langouche
Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance Bram Peeters · Fabian Güiza · Eva Boonen · Phlippe meersseman · Lies Langouche · Greet Van den Berghe · Greet Van den Berghe
Reciprocal crosstalk between autophagic and endocrine signaling in metabolic homeostasis Gemma Pujadas · Daniel J. Drucker · Daniel J. Drucker
Serum Calcium to Phosphorous Ratio (Ca/P) As a Simple, Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism (PHPT) Janet W. Rich-Edwards · Janet W. Rich-Edwards · Ursula B. Kaiser · Grace Chen · JoAnn E. Manson · JoAnn E. Manson · Jill M. Goldstein · Jill M. Goldstein
In Memoriam: Melvin M. Grumbach (1925-2016) Rohit A. Sinha · Brijesh K. Singh · Paul M. Yen · Paul M. Yen
Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era Walter L. Miller · Walter L. Miller
Immune Modulation of Brown(ing) Adipose Tissue in Obesity Qing Fang · Akima S. George · Michelle L. Brinkmeier · Amanda H. Mortensen · Peter Gergics · Leonard Y.M. Cheung · Alexandre Z. Daly · Adnan Ajmal · María Inés Pérez Millán · A. Bilge Ozel · Jacob O. Kitzman · Ryan E. Mills · Jun Li · Sally A. Camper · Sally A. Camper
日周リズムと睡眠妨害:原因,代謝的帰結及び予防対策 Susan M. van den Berg · Andrea D. van Dam · Patrick C. N. Rensen · Menno P.J. de Winther · Menno P.J. de Winther · Esther Lutgens · Esther Lutgens · Esther Lutgens
Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology Bruno Di Jeso · Peter Arvan · Peter Arvan

Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
Endocrine Reviews | 2018
M Van Den Berg Susan · D Van Dam Andrea · C N Rensen Patrick · P J De Winther Menno · Lutgens Esther · Lutgens Esther
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment
Endocrine Reviews | 2018
Teresa Maria Seccia · Brasilina Caroccia · Elise P. Gomez-Sanchez · Celso E. Gomez-Sanchez · Gian Paolo Rossi · Gian Paolo Rossi
The science of obesity management: An endocrine society scientific statement
Endocrine Reviews | 2018
Claus Højbjerg Gravholt · Simon Chang · Mikkel Wallentin · Jens Fedder · Philip J. Moore · Anne Skakkebæk · Anne Skakkebæk
The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism
Endocrine Reviews | 2018
George A. Bray · William E. Heisel · Ashkan Afshin · Michael D. Jensen · William H. Dietz · Michael W. Long · Robert F. Kushner · Stephen R. Daniels · Thomas A. Wadden · Adam Gilden Tsai · Frank B. Hu · John M. Jakicic · Donna H. Ryan · Bruce M. Wolfe · Thomas H. Inge · Thomas H. Inge · Thomas H. Inge
The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations
Endocrine Reviews | 2018
Vincent Prevot · Vincent Prevot · Bénédicte Dehouck · Bénédicte Dehouck · Ariane Sharif · Ariane Sharif · Philippe Ciofi · Philippe Ciofi · Paolo Giacobini · Paolo Giacobini · Jerome Clasadonte · Jerome Clasadonte · Jerome Clasadonte